ChiCTR2600118102 版本V1.0 版本创建时间2026/02/02 11:30:31 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600118102 

最近更新日期:

Date of Last Refreshed on:

2026-02-02 11:30:28 

注册时间:

Date of Registration:

2026-02-02 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

双相抑郁自杀行为的基因影像学特征

Public title:

Genetic imaging characteristics of suicidal behavior in bipolar depression

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于“前额叶-扣带-纹状体”环路探究双相抑郁自杀行为的基因影像学特征

Scientific title:

The study to explore the gene imaging characteristics of suicidal behavior in bipolar depression focused on the prefrontal-cingulate-striatum circuit

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

田水 

研究负责人:

田水 

Applicant:

Tian Shui 

Study leader:

Tian Shui 

申请注册联系人电话:

Applicant telephone:

+86 159 0517 8576

研究负责人电话:

Study leader's telephone:

+86 159 0517 8576

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

tianxueshui@126.com

研究负责人电子邮件:

Study leader's E-mail:

tianxueshui@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国江苏省南京市鼓楼区汉中路140号

研究负责人通讯地址:

中国江苏省南京市鼓楼区汉中路140号

Applicant address:

140 Hanzhong Road, Gulou District, Nanjing, Jiangsu, China

Study leader's address:

140 Hanzhong Road, Gulou District, Nanjing, Jiangsu, China

申请注册联系人邮政编码:

Applicant postcode:

210100

研究负责人邮政编码:

Study leader's postcode:

210100

申请人所在单位:

南京医科大学第一附属医院

Applicant's institution:

the First Affiliated Hospital with Nanjing Medical University

研究负责人所在单位:

南京医科大学第一附属医院

Affiliation of the Leader:

the First Affiliated Hospital with Nanjing Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025-SR-1075

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南京医科大学第一附属医院伦理委员会

Name of the ethic committee:

The Ethics Committee of the First Affiliated Hospital of Nanjing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-12-09 00:00:00

伦理委员会联系人:

王嘉楠

Contact Name of the ethic committee:

Wang Jianan

伦理委员会联系地址:

中国江苏省南京市鼓楼区广州路300号江苏省人民医院7号楼3楼

Contact Address of the ethic committee:

3rd Floor Building 7 Jiangsu Provincial People's Hospital, No. 300 Guangzhou Road, Gulou District, Nanjing, Jiangsu, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 25 6830 6360

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南京医科大学第一附属医院

Primary sponsor:

the First Affiliated Hospital with Nanjing Medical University

研究实施负责(组长)单位地址:

中国江苏省南京市鼓楼区汉中路140号

Primary sponsor's address:

140 Hanzhong Road, Gulou District, Nanjing, Jiangsu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏

市(区县):

南京

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

南京医科大学第一附属医院

具体地址:

中国江苏省南京市鼓楼区汉中路140号

Institution
hospital:

the First Affiliated Hospital with Nanjing Medical University

Address:

140 Hanzhong Road, Gulou District, Nanjing, Jiangsu, China

经费或物资来源:

国家自然科学基金(82401788);江苏省基础计划自然科学基金青年基金项目(BK20241120)

Source(s) of funding:

The National Natural Science Foundation of China (82401788); Jiangsu Provincial Natural Science Youth Fund (BK20241120)

Target disease:

Mental disease

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

本研究拟聚焦“前额叶-扣带-纹状体”环路探究双相抑郁为主体的精神疾病中伴随自杀行为的患者神经环路损害模式的多样性。再此基础上,识别与神经环路损伤关联的易感基因,解析神经环路损伤的动态演变规律。最后,构建基于神经影像和易感基因筛查的自杀行为预警模型,并验证模型有效性。  

Objectives of Study:

This study aims to focus on the "prefrontal-cingulate-striatum" circuit to explore the diversity of neural circuit damage patterns in patients with bipolar depression as the main mental disorder accompanied by suicidal behavior. On this basis, identify the susceptibility genes associated with neural circuit damage and analyze the dynamic evolution rules of neural circuit damage. Finally, construct a suicide behavior early warning model based on neuroimaging and susceptibility gene screening, and verify the model's effectiveness.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 符合DSM-5双相障碍抑郁发作诊断标准; 2. 考虑年龄是自杀行为的危险因素,本课题关注成年早期的患者,故年龄>=18岁且<=35岁; 3. 汉族; 4. 右利手; 5. 17项Hamilton抑郁量表评分>=17。

Inclusion criteria

1. Meets the diagnostic criteria for depressive episode of bipolar disorder as defined by DSM-5; 2. Considering that age is a risk factor for suicidal behavior, this study focuses on patients in early adulthood, so the age range is >=18 and <=35 years old; 3. Han ethnicity; 4. Right-handed; 5. Hamilton Depression Scale score of 17 items >=17.

排除标准:

1. 磁共振扫描幽闭恐惧症; 2. 伴有幻觉、妄想等精神病性症状; 3. 明显心理和躯体的诱发因素; 4. 存在严重躯体疾病史,脑器质性疾病史; 5. 电休克治疗半年内者。

Exclusion criteria:

1. Magnetic resonance scan for claustrophobia; 2. Accompanied by psychotic symptoms such as hallucinations and delusions; 3. Obvious psychological and physical triggering factors; 4. Has a history of serious physical diseases and brain organic diseases; 5. Those who have received electroconvulsive therapy within half a year.

研究实施时间:

Study execute time:

From 2026-01-01 00:00:00 To 2028-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-02-24 00:00:00 To 2026-12-09 00:00:00  

干预措施:

Interventions:

组别:

伴自杀未遂双相抑郁组

样本量:

120

Group:

Bipolar depression group with attempted suicide

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

不伴自杀未遂双相抑郁组

样本量:

120

Group:

Bipolar depression group without attempted suicide

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

健康对照组

样本量:

200

Group:

Bipolar depression group without attempted suicide

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

外部验证组-伴自杀未遂

样本量:

50

Group:

External validation group - with attempted suicide

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

外部验证组-不伴自杀未遂

样本量:

50

Group:

External validation group - No attempted suicide

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏 

市(区县):

南京 

Country:

China 

Province:

Jiangsu 

City:

Nanjing 

单位(医院):

南京医科大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital with Nanjing Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

前额叶-扣带-纹状体”环路灰质体积

指标类型:

主要指标

Outcome:

The gray matter volume of the "prefrontal lobe - cingulate - striatum" circuit

Type:

Primary indicator

测量时间点:

测量方法:

functional magnetic resonance imaging

Measure time point of outcome:

Measure method:

指标中文名:

前额叶-扣带-纹状体”环路低频振幅

指标类型:

主要指标

Outcome:

Low-frequency amplitude of the "prefrontal - cingulate - striatum" circuit

Type:

Primary indicator

测量时间点:

测量方法:

问诊

Measure time point of outcome:

Measure method:

指标中文名:

前额叶-扣带-纹状体”环路功能连接

指标类型:

主要指标

Outcome:

Functional connection of the "prefrontal lobe - cingulate - striatum" circuit

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

与神经环路损伤关联的易感基因

指标类型:

主要指标

Outcome:

Susceptibility genes associated with neural circuit damage

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

多基因风险评分

指标类型:

主要指标

Outcome:

Polygenic risk score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

双层自杀行为预警模型准确率

指标类型:

主要指标

Outcome:

The accuracy rate of the two-layer suicide behavior early warning model

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 35 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表、电子管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF and electronic management system

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-02-02 11:30:28